Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 7:47 PM

Eli Lilly & Company

Eli Lilly & Company - Click to view image in its original context
Eli Lilly & Company
Type: Company
Name: Eli Lilly & Company (Eli Lilly and Company)
First Reported 11/19/2009 - Updated 11/19/2009 - 3 Documents
Here’s an executive compensation tidbit for your afternoon reading, courtesy of Eli Lilly. Steven Paul, Lilly’s R&D chief, will receive a cash severance payment of $2 million in connection with his retirement next year, the company said in an SEC filing ... [WSJ.com: Health Blog - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Alkermes, Inc. (USA)AstraZeneca Plc (UK)Boehringer Ingelheim GmbH (Germany)Bristol-Myers Squibb (USA)Cephalon, Inc. (USA)Dainippon Sumitomo Pharma Co., Ltd. (Japan)Elan Corporation Plc (Ireland)Eli Lilly and Co. (USA)Fabre-Kramer Pharmaceuticals, Inc. ... [News-Medical.Net - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Securitas AB - Click to view 360-page
Securitas AB
Barbara Jean Wingo Burnett 62, of Indianapolis, passed away November 15, 2009. She retired after 30 years from AT&T as an operator and Securitas as security for Eli Lilly. Survivors include two daughters, Mechelle Burnett and Tonya Massey; son, Christopher ... [Indianapolis Star - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents (in Health)
DALLAS, Nov. 20, 2009 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biopharmaceutical company Vivus Inc. (Nasdaq: VVUS). The report includes financial, comparative and investment analyses, and industry information you need ... [Street Insider - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/8efb21/managed_markets_ac) has announced the addition of the "Managed Markets Account Management: Assessing the Performance of Account Executives" report to their offerin ... [Forbes.com - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Unum Group - Click to view 360-page
Unum Group
When I was of , I stump on a small detail of the company’s funds. Take the flagship Stock Fund for example, as of September 30, 2009, the fund’s 83 stocks have an average forward Price-to-Earning ratio of 13.2, that is compared to S&P 500’s 21.4. The ... [Guru Focus - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents (in Health)
One reason drug companies need additional revenue is because employee whistleblowers have found the nerve to report the industry's crooked business practices—leading to multi-million dollar payouts to injured patients plus fines for legal violations. ... [Mother Jones - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
The Indianapolis International Airport took home the coveted Monumental Award as the most significant project of the year in Marion County as determined by Keep Indianapolis Beautiful Inc. The organization presented a total of 37 awards last night that ... [Inside INdiana Business - 11/20/2009]
First Reported 6 hours ago - Updated 6 hours ago - 1 Documents (in Health)
Companies: AstraZeneca PLC (AZN), Eli Lilly & Co. (LLY) Recently, AstraZeneca plc (AZN) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its blood clot preventer Brilinta (ticagrelor). Brilinta ... [Zibb - 6 hours ago]
First Reported 22 hours ago - Updated 22 hours ago - 1 Documents (in Health)
Some 60% of Americans say that when they need medical information, they turn to the Internet. At least half the group uses social networks to consult one another on symptoms, diagnoses, and treatments, according to surveys on Web behavior. Pharmaceutical ... [BusinessWeek - 22 hours ago]
First Reported 22 hours ago - Updated 22 hours ago - 1 Documents (in Corporate Deals)
The marriage between Merck (NYSE: MRK) and Schering-Plough is already starting to produce offspring. The only question is whether the fertility treatment for its pipeline was worth it.Today, the drugmaker received a positive opinion from the EU's Committee ... [Motley Fool - 22 hours ago]
First Reported 13 hours ago - Updated 13 hours ago - 1 Documents
WASHINGTON -- The Senate scaled back proposed fees on Eli Lilly and Co., Cook Medical and other makers of medical devices as part of the health-care bill that could get its first test vote today.The bill would impose annual fees on the industry totaling ... [Indianapolis Star - 13 hours ago]

Quotes

...Ramy Farid, president, Schrödinger, a scientific leader in developing state-of-the-art chemical simulation software. "Cycle has provided us with a highly robust solution for performing computations on the cloud, significantly reducing the demands on our in-house compute resources." CIO, CTO & Developer Resources Specifically with the pharmaceutical and life sciences industry, Cycle's comprehensive C and cloud solutions portfolio...
...standards should be replaced with Indian Pharmacopoeia standards of insulin injection soluble and insulin injection isophane formulations. "The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955" says the notifications
...shows that the onset of erection appears to be cut in half, 30 minutes or less compared with its competitors' drugs Viagra, Cialis and Levitra. "Avanafil, Viagra and Cialis work by blocking the PDE5 enzyme, but Avanafil appears to act more quickly than the other two blockbuster drugs. But the hurdle facing the Company centers upon its potential for rapid commercialization, as the patent for Viagra expires one year after the expected introduction of Avanafil in 2012. It's feared that cheaper generic versions of Viagra will pose stiff competition just when Avanafil breaks into the marketplace." To read the entire report visit: http://www.beaconequity.com/i/VVUS
...As Dr JohnJohn C Lechleiter, chief executive officer of Global Top Companies for Leaders winner Eli Lilly, notes, "There were a lot of people here to help us win the last war, but we need to develop people to win the next war–all the while continuing to ground ourselves in the company's values. We take the long view in respect to people development; we still talk to people about building careers here.”"

More Content

All (1573) | News (1328) | Reports (1) | Blogs (199) | Audio/Video (8) | Fact Sheets (18)
sort by: Date | Relevance
Cloud Computing Fuels Rapid Growth for Cycle Co... [Cloud Computing Journal - 2 hours ago]
MediaTile Announces new Chairman of the Board [Digital Signage Weekly - 2 hours ago]
AstraZeneca Seeks FDA Approval [Individual.com - 6 hours ago]
AstraZeneca Seeks FDA Approval - Zibb.com [Zibb - 6 hours ago]
Innovation Goes Downtown [BusinessWeek - 10 hours ago]
Bill reduces proposed fees on medical device ma... [Indianapolis Star - 13 hours ago]
Big Pharma Mergers: Good News Or Bad? [Yahoo! Canada - 18 hours ago]
This Baby Is a Nice Addition [Motley Fool - 22 hours ago]
Why Pharma Doesn't Twitter [BusinessWeek - 22 hours ago]
Airport Lands Monumental Award [Inside INdiana Business - 11/20/2009]
Research and Markets: Strategies for Building E... [Forbes.com - 11/20/2009]
Low PE Dodge & Cox Stocks: News Corp., Unum... [Guru Focus - 11/20/2009]
How We Pay for Big Pharma's Malpractice [Mother Jones - 11/20/2009]
After the FDA’s social media hearings, what’s n... [eyeforpharma.com - 11/20/2009]
Competition in Blood - Thinners: Win - Win for ... [Seeking Alpha - 11/20/2009]
After Re-Engineering Itself, Verdezyne Sets Cou... [Xconomy - 11/20/2009]
Sonoco Named One of the 25 Top Companies for Le... [Forbes.com - 11/20/2009]
Research and Markets: Strategies for Building E... [RBC Dain Rauscher - 11/20/2009]
NPPA revises prices of 119 formulation packs [PharmaBiz - 11/20/2009]
Sonoco Named One of the 25 Top Companies for Le... [Business Wire via MSN Money - 11/20/2009]
AstraZeneca files Brilinta in US [Pharmafocus - 11/20/2009]
Research and Markets: Managed Markets Account M... [Forbes.com - 11/20/2009]
Trading Review for Vivus Inc. Issued by Beacon ... [Street Insider - 11/20/2009]
Global market for anti-depressants on a decline [News-Medical.Net - 11/20/2009]
Competition in Blood-Thinners: Win-Win for Ever... [Seeking Alpha - 11/20/2009]
Retiring Lilly research exec Steven Paul gets $... [Indianapolis Star - 11/20/2009]
Effient tabs added as treatment option in 2 cli... [PharmaBiz - 11/20/2009]
Specialty Pharmaceuticals: Therapy Class Review... [Pharmacy Times - 11/20/2009]
CORRECT:Justice Dept's Health-Care Fraud Caselo... [Nasdaq - 11/20/2009]
10 Companies With Top Yields, Dividend Growth [Investors Business Daily - 11/20/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Plavix vs. Effient [Corante - 16 hours ago]
The InVivo Blog has a good article on a controversy in the blood-thinning market. Plavix (clopidogrel) has a very strong share of that, of course, but since Effient ...
For Lilly’s R&D Chief, a $2 Million Exit Ha... [WSJ.com: Health Blog - 11/19/2009]
Here’s an executive compensation tidbit for your afternoon reading, courtesy of Eli Lilly. Steven Paul, Lilly’s R&D chief, will receive a cash severance payment ...
Plavix vs. Effient [In the Pipeline - 11/19/2009]
The InVivo Blog has a good article on a controversy in the blood-thinning market. Plavix (clopidogrel) has a very strong share of that, of course, but since Effient ...
Oral-lyn vs. Afresa: How Generex Will Beat Mann... [Healthcare Sector and Stocks Analysis from Seek ... - 11/19/2009]
R.J Steffens submits:As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns ...
Oral-lyn vs. Afresa: How Generex Will Beat Mann... [Biotech Sector and Stocks Analysis from Seeking ... - 11/19/2009]
R.J Steffens submits:As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
WSJ WHAT'S NEWS MIDDAY, SEPTEMBER 14, 2009 [Wall Street Journal What's News - 09/14/2009]
The WSJ What's News Late Edition, August 4, 2009 [Wall Street Journal What's News - 08/04/2009]
MTS28 - Joseph DeRisi - New Tech Approaches to ... [Mefeedia Video Tag : nanotechnology - 06/02/2009]
Community Achievers Part 1 [Mefeedia Video Tag : medicine - 04/19/2009]
Community Achievers Part 1 [Mefeedia Video Tag : medicine - 04/19/2009]
1 2

  •  
  •  
  •